Investigational drug · Phase 2
E2086
Not approved by FDA. In 1 industry-sponsored Phase 2 or 3 trial that is active or finished in the last two years, most often for Narcolepsy.
Phase 2Last checked: Nov 19, 2026Latest source record: May 14, 2026 (newest trial update)Source: ClinicalTrials.govMethods & limitations
Highest phase
Phase 2
Industry-sponsored trials
Phase 2 and 3 trials
1
1 still active
All registered trials
6
Any phase or sponsor naming "E2086"
First trial start
2026
Mar 26, 2026
Sponsors
Lead sponsors of its Phase 2 and 3 trials.
All registered trials by phase
Every ClinicalTrials.gov drug study naming "E2086", any sponsor or status.
Conditions studied
As listed on its trial records.
- Narcolepsy
Approved drugs for the same conditions: Narcolepsy · Neurology
Largest trials
Live from ClinicalTrials.gov: studies naming "E2086" as an intervention, largest first.
Eisai Inc.Eisai
NCT07766369 · 93 participants (planned) · Start Aug 12, 2026 · Primary completion Nov 12, 2026
Drug: E2086 · For: Healthy Volunteers
Sites: Austin, Texas
Eisai Inc.Eisai
NCT07493265 · 64 participants (planned) · Start Mar 26, 2026 · Primary completion Feb 14, 2027
Drug: E2086; Placebo · For: Narcolepsy
Sites: Santa Ana, California; Brandon, Florida; Medley, Florida · 57 sites in all
Eisai Inc.Eisai
NCT05745207 · 53 participants · Start Feb 20, 2023 · Primary completion Jan 18, 2024
Drug: E2086; Placebo · For: Healthy Volunteers
Sites: San Antonio, Texas
Eisai Inc.Eisai
NCT06481488 · 32 participants · Start Jun 25, 2024 · Primary completion Dec 13, 2024
Drug: E2086; Placebo · For: Healthy Volunteers
Sites: Glendale, California
Eisai Inc.Eisai
NCT06462404 · 22 participants · Start Jun 20, 2024 · Primary completion Mar 17, 2025
Drug: E2086; E2086 Placebo and 2 more · For: Narcolepsy Type 1 (NT1)
Sites: Santa Ana, California; Miami, Florida; Macon, Georgia · 14 sites in all
- A Study to Determine the Metabolism and Excretion of [14C]E2086 in Healthy Male ParticipantsCompleted
Eisai Inc.Eisai
NCT07308236 · 10 participants · Start Dec 31, 2025 · Primary completion Jun 12, 2026
Drug: E2086 · For: Healthy Volunteers
Sites: Madison, Wisconsin
Newest research
PubMed records naming it or its code names, newest first.
No PubMed records name it yet, which is common for early code-named drugs.
Names are merged from how sponsors list this drug on ClinicalTrials.gov, so an alias can occasionally belong to a related compound. Development status changes faster than registry records do. More from Eisai.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.